PubMed Health⌕ Search

PubMed · 16447684

[Sampling and conveyance of mail testing].

Abstract

In mail testing, a testee collects samples at home from his or her own body, and mails them to the medical institution. Because the testee does not need to attend the medical institution, an advantage of mail testing is that it is not time-consuming. Because the amount of sample is small and time from sampling to measurement is long, the manner of collecting and transporting samples are important factors affecting the precision of the result. There is the risk that inappropriate sample picking can occur, as the testee, who is not skilled in medical testing, may obtain the sample. Moreover, the samples may include blood, urine, secretions, and so on. Depending on the purpose of the test, the transport and sampling method varies, and the character of the sampling device and transport method influence the procedure required. I describe collection methods and other issues in this paper according to medical examination item, sample, and sampling.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kouji Higashino. 2005. [Sampling and conveyance of mail testing].. https://pubmed.ncbi.nlm.nih.gov/16447684/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS.

Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) is the precursor of Delta9-tetrahydrocannabinol (Delta9-THC) in hemp plants. During smoking, the non-psychoactive Delta9-THCA-A is converted to Delta9-THC, the main psychoactive component of marihuana and hashish. Although the decarboxylation of Delta9-THCA-A to Delta9-THC was assumed to be complete--which means that no Delta9-THCA-A should be detectable in urine and blood serum of cannabis consumers--we found Delta9-THCA-A in the urine and blood serum samples collected from police controls of drivers suspected for driving under the influence of drugs (DUID). For LC-MS/MS analysis, urine and blood serum samples were prepared by solid-phase extraction. Analysis was performed with a phenylhexyl column using gradient elution with acetonitrile. For detection of Delta9-THCA-A, the mass spectrometer (MS) (SCIEX API 365 triple-quadrupole MS with TurboIonSpray source) was operated in the multiple reaction monitoring (MRM) mode using the following transitions: m/z357 --> 313, m/z357 --> 245 and m/z357 --> 191. Delta9-THCA-A could be detected in the urine and blood serum samples of several cannabis consumers in concentrations of up to 10.8 ng/ml in urine and 14.8 ng/ml in serum. The concentration of Delta9-THCA-A was below the Delta9-THC concentration in most serum samples, resulting in molar ratios of Delta9-THCA-A/Delta9-THC of approximately 5.0-18.6%. Only in one case, where a short elapsed time between the last intake and blood sampling is assumed, the molar ratio was 18.6% in the serum. This indicates differences in elimination kinetics, which need to be investigated in detail.

Blood Chemical Analysis↗